The US Food and Drug Administration (FDA) has approved marketing of the BrainsWay Deep Transcranial Magnetic Stimulation System for treatment of obsessive-compulsive disorder (OCD), after reviewing data from a multi-center study.
Brainsway, an Israeli company that specializes in developing and providing advanced technology solutions for the treatment of a variety of brain disorders, explained that the treatment performs magnetic stimulation of the brain’s frontal lobe and its networks, targeting previously unreachable areas of the brain using its helmet-like device, which allows it to effectively treat OCD, as well as other disorders including schizophrenia and depression. JewishPress
Brainsway
BrainsWay is ushering in a new era of brain disorder treatment. Through ongoing investment in R&D and in research initiatives ranging from large-scale multicenter trials to personalized medicine studies, BrainsWay represents the next-generation of treatments for depression, OCD, and other brain disorders, achieving outcomes not thought possible with traditional medical solutions.
This is amazing for more reasons than for OCD. This is the first FDA Cleared non-invasive medical device for the treatment of OCD.
But there are other conditions that Brainsway can treat, and they have been doing so for 20 years in Israel. How did we not hear about this sooner? I’m sure there are thousands of persons who could truly benefit from this treatment.
Alzheimer’s
Bipolar
Autism
Depression
MSC
Schizophrenia
Parkinsons
No comments:
Post a Comment